Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
386,127,219
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
46,484,322
-
Shares change
-
-731,936
-
Total reported value, excl. options
-
$54,406,276
-
Value change
-
-$819,975
-
Put/Call ratio
-
165%
-
Number of buys
-
28
-
Number of sells
-
-30
-
Price
-
$1.17
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q4 2022
79 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share as of Q4 2022.
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46,484,322 shares
of 386,127,219 outstanding shares and own 12% of the company stock.
Largest 10 shareholders include Caligan Partners LP (8,576,799 shares), Indaba Capital Management, L.P. (7,446,229 shares), PRIMECAP MANAGEMENT CO/CA/ (4,616,673 shares), Neuberger Berman Group LLC (4,352,630 shares), VANGUARD GROUP INC (3,955,968 shares), NEEDHAM INVESTMENT MANAGEMENT LLC (3,797,157 shares), MORGAN STANLEY (3,055,000 shares), BOOTHBAY FUND MANAGEMENT, LLC (2,302,278 shares), BlackRock Inc. (1,407,371 shares), and Price Jennifer C. (972,754 shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.